Richard S. Lindahl, EVP, Chief Financial Officer at Emergent BioSolutions Inc. (EBS), bought 3,000 shares at $37.46 ($112K) on 2021-11-15, disclosed to the SEC on 2021-11-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |